Rafferty Asset Management, LLC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$2,425,372
+95.4%
507,400
+117.0%
0.01%
+75.0%
Q1 2023$1,241,388
-6.4%
233,783
+10.7%
0.01%
-27.3%
Q4 2022$1,326,192
-4.2%
211,177
+60.9%
0.01%
-26.7%
Q3 2022$1,385,000131,2390.02%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders